CNS Neuroscience & Therapeutics
© 2012 Blackwell Publishing Ltd

Edited By: Ding-Feng Su
Impact Factor: 3.492
ISI Journal Citation Reports © Ranking: 2010: 62/249 (Pharmacology & Pharmacy); 83/237 (Neurosciences)
Online ISSN: 1755-5949
Recently Published Issues
Current Issue:February 2012
Volume 18, Issue 2
Volume 18, Issue 1
Volume 17, Issue 6
Volume 17, Issue 5
Volume 17, Issue 4
Most Cited Neuroscience Papers since 2010 - CNS Neuroscience & Therapeutics
REVIEW: Curcumin and Alzheimer's Disease
F Stephen HODI
REVIEW: Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?
Alessandro Martorana, Zaira Esposito, Giacomo Koch
REVIEW: Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
Deranda B Lester, Tiffany D. Rogers, Charles D. Blaha
REVIEW: Genome-Wide Findings in Schizophrenia and the Role of Gene–Environment Interplay
Ruud Van Winkel, Gabriel Esquivel, Gunter Kenis, Marieke Wichers, et al.
REVIEW: Dopamine and Glutamate in Huntington's Disease: A Balancing Act
Véronique M. André, Carlos Cepeda, Michael S. Levine
REVIEW: Adenosine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
K. Fuxe, D. Marcellino, D. O. Borroto-Escuela, M. Guescini, et al
Online Themed Issues - 'Stroke' & 'Neurodegenerative Diseases'
Most Read Neuroscience Papers from 2011 - CNS Neuroscience & Therapeutics
REVIEW: Dopamine and Oxytocin Interactions Underlying Behaviors: Potential Contributions to Behavioral Disorders
Tracey A. Baskerville, Alison J. Douglas
REVIEW: Parkinson's Disease Dementia and Potential Therapeutic Strategies
John N. Caviness, LihFen Lue, Charles H. Adler, Douglas G. Walker
REVIEW: Neurosyphilis: A Historical Perspective and Review
Khalil G. Ghanem
REVIEW: Oxytocin: Crossing the Bridge between Basic Science and Pharmacotherapy
Cedric Viero, Izumi Shibuya, Naoki Kitamura, Alexei Verkhratsky, et al
RESEARCH: Treatment Strategies for Dosing the Second Generation Antipsychotics
Thomas L. Schwartz, Stephen M. Stahl
REVIEW: Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia
Magdalena Nord, Lars Farde
EXPEDITED: publish your clinical trials faster
1755-5949/asset/homepages/stopwatch2.jpg?v=1&s=49f32ded36eb0fff977f92928e52c639c48b0d5c)
EXPEDITED is the new priority publication service from CNS: Neuroscience & Therapeutics exclusively for well conducted, well reported clinical trials.
- Priority peer review: 7 working days from online submission.
- Priority proofs: 7 working days from 'accept' decision.
- Priority online: 7 working days from proof approval to Early View publication.
- Priority print: 'Late Breaker' publication in the next print issue. Click here for more information.

1755-5949/asset/olbannerleft.jpg?v=1&s=5d15a71cf86a8b36c0cf2a023a874dade6248389)
1755-5949/asset/olbannercenter.jpg?v=1&s=990bd1743e46751c21567339d72c4daf55e0d6f5)
1755-5949/asset/homepages/Virtual_Issue_Banner.gif?v=1&s=2cad81721b30e68b29f6d105768d4f6507d85889)
1755-5949/asset/homepages/Relaunch_Banner.gif?v=1&s=6725d7d5889612dbffc33e27ac9c6d8edcb92925)